News & Events
Through Imperial Consultants, LCAworks members Dr Richard Murphy, Dr Jeremy Woods and Miss Miao Guo have carried out a full life-cycle analysis of the product as a major part of Coca Cola’s development programme.
The bottle is made by a process that turns sugar cane and molasses, a by-product of sugar production, into a monoethylene glycol, a major component of PET plastic. The packaging is made of up to 30% plant-based material and can be recycled in the existing recycling infrastructure.
Research from LCAworks has shown that the bottle has a significantly reduced carbon footprint compared to petroleum-based PET plastic bottles. Coca-Cola North America have already begun to pilot this bottle in select markets.
About the awards
The DuPont packaging awards began in 1986 and since 1989 have recognised environmental achievements in the area of packaging.
The award is the industry’s longest running, independently judged awards honour materials, processing, technology and service achievements that demonstrate excellence in packaging innovation, sustainability and cost/waste reduction.
For more information visit the Dupont Awards for Packaging Innovation Awards website.
Share post:
Latest news, insights and events
Imperial College London and Imperial Consultants sign partnership agreement with City Proton
The partnership was signed last week at Imperial with representatives from Imperial’s research team, City Proton including Ken Anderson, Chairman, Imperial Consultants and Imperial Innovations, as well as Professor James Stirling, Provost of Imperial College London. read more
Electric Insights quarterly report – Jan-Mar 2020
Commissioned by Drax and delivered by Dr iain Staffell and team, the quarterly Electric Insights reports analyse raw data made publicly available by National Grid and Elexon, which run the electricity and balancing market respectively, and Sheffield Solar. read more
Cystic Fibrosis expert from Imperial named on clinical advisory board for Proteostasis Therapeutics
Professor Jane Davies of Imperial College London has been appointed to Proteostasis Therapeutics’ Cystic Fibrosis clinical advisory board, in a collaboration facilitated by Imperial Consultants (ICON). read more